Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the top strong buy stocks under $5 to buy now. In a report released on August 14, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ:ABCL), setting a price target of $10.00.

Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?

A research team analyzing data on a computer screen, uncovering details about the antibody discovery platform.

AbCellera Biologics Inc. (NASDAQ:ABCL) reported its fiscal Q2 results on August 7, stating that it hit two critical milestones in the quarter: attaining authorization for the initiation of Phase 1 studies for both ABCL635 and ABCL575.

Carl Hansen, Ph.D., founder and CEO of AbCellera Biologics Inc. (NASDAQ:ABCL), told investors that the company successfully began dosing the first participants in the Phase 1 study of ABCL635, marking a “landmark achievement” for the company as it completes its transition to a clinical-stage biotechnology company.

Hansen added that with more than $750 million in available liquidity, AbCellera Biologics Inc. (NASDAQ:ABCL) is well-positioned to continue the execution of its strategy.

AbCellera Biologics (NASDAQ:ABCL) solves antibody discovery problems by integrating data science, technology, infrastructure, and interdisciplinary teams.

The company develops and discovers antibody medicines for indications across therapeutic areas, including metabolic and endocrine conditions, cancer, and autoimmune disorders.

It boasts technology platforms that unlock drug classes, modalities, and targets, including T-cell engagers, peptide-MHCs, and transmembrane proteins.

While we acknowledge the potential of ABCL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ABCL and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.